SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (2668)9/29/2001 9:26:31 PM
From: scaram(o)ucheRespond to of 4974
 
>> With TELK offering at 6.5$, I guess i get shot at buying back this stock in the low 5's. Stocks with secondary offerings all have been weak after the offering was closed, probably due to hedging activities of underwriters. <<

I dunno. Remember that this is where the "hell bent" buyers were that drove it up through the lousy market. If that was motored by overt clinical responses to 286, then it may, again, stand out from the crowd.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News